Absolute Metabolite Concentrations and Implied Enzyme Active Site Occupancy in Escherichia coli

Department of Chemistry and Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, USA.
Nature Chemical Biology (Impact Factor: 13). 07/2009; 5(8):593-9. DOI: 10.1038/nchembio.186
Source: PubMed


Absolute metabolite concentrations are critical to a quantitative understanding of cellular metabolism, as concentrations impact both the free energies and rates of metabolic reactions. Here we use LC-MS/MS to quantify more than 100 metabolite concentrations in aerobic, exponentially growing Escherichia coli with glucose, glycerol or acetate as the carbon source. The total observed intracellular metabolite pool was approximately 300 mM. A small number of metabolites dominate the metabolome on a molar basis, with glutamate being the most abundant. Metabolite concentration exceeds K(m) for most substrate-enzyme pairs. An exception is lower glycolysis, where concentrations of intermediates are near the K(m) of their consuming enzymes and all reactions are near equilibrium. This may facilitate efficient flux reversibility given thermodynamic and osmotic constraints. The data and analyses presented here highlight the ability to identify organizing metabolic principles from systems-level absolute metabolite concentration data.

Full-text preview

Available from:
  • Source
    • "In fact , metabolite measurements in E . coli and S . cerevisiae have shown that most enzymes in central carbon metabolism are not saturated , with substrate levels being close to their respective K M values ( Bennett et al . , 2009 ; Fendt et al . , 2010 ) . A recent study in B . subtilis showed that transcriptional regulation is insuffi - cient to explain the observed flux change for growth in differ - ent carbon sources ( Chubukov et al . , 2013 ) . Interestingly , the authors observed that the changes in substrate concentrations were also insufficient to explai"
    [Show abstract] [Hide abstract]
    ABSTRACT: Modeling cellular metabolism is fundamental for many biotechnological applications, including drug discovery and rational cell factory design. Central carbon metabolism (CCM) is particularly important as it provides the energy and precursors for other biological processes. However, the complex regulation of CCM pathways has still not been fully unraveled and recent studies have shown that CCM is mostly regulated at post-transcriptional levels. In order to better understand the role of allosteric regulation in controlling the metabolic phenotype, we expand the reconstruction of CCM in Escherichia coli with allosteric interactions obtained from relevant databases. This model is used to integrate multi-omics datasets and analyze the coordinated changes in enzyme, metabolite, and flux levels between multiple experimental conditions. We observe cases where allosteric interactions have a major contribution to the metabolic flux changes. Inspired by these results, we develop a constraint-based method (arFBA) for simulation of metabolic flux distributions that accounts for allosteric interactions. This method can be used for systematic prediction of potential allosteric regulation under the given experimental conditions based on experimental data. We show that arFBA allows predicting coordinated flux changes that would not be predicted without considering allosteric regulation. The results reveal the importance of key regulatory metabolites, such as fructose-1,6-bisphosphate, in controlling the metabolic flux. Accounting for allosteric interactions in metabolic reconstructions reveals a hidden topology in metabolic networks, improving our understanding of cellular metabolism and fostering the development of novel simulation methods that account for this type of regulation.
    Frontiers in Bioengineering and Biotechnology 10/2015; 3. DOI:10.3389/fbioe.2015.00154
  • Source
    • "However, since the availability of commercial U-13 C-labelled isotopomers is limited and they are often prohibitively expensive, in vivo synthesis of U-13 C-labelled compounds is required using suitable microorganisms grown in U-13 C-labelled glucoselimited culture media. Absolute intracellular concentrations of metabolites in a sample can then be calculated by adding known amounts of U-13 C-labelled cell extract prior to the extraction procedure (Bennett et al. 2009; Mashego et al. 2004). The most suitable method for this isotope ratiobased MS (IR-MS) technique is to use the same organism for generating U-13 C-labelled cell extracts which can cover all of intracellular metabolites for absolute quantification (Mashego et al. 2004; Wu et al. 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human African trypanosomiasis is a neglected tropical disease caused by the protozoan parasite, Trypanosoma brucei. In the mammalian bloodstream, the trypanosome's metabolism differs significantly from that of its host. For example, the parasite relies exclusively on glycolysis for energy source. Recently, computational and mathematical models of trypanosome metabolism have been generated to assist in understanding the parasite metabolism with the aim of facilitating drug development. Optimisation of these models requires quantitative information, including metabolite concentrations and/or metabolic fluxes that have been hitherto unavailable on a large scale. Here, we have implemented an LC-MS-based method that allows large scale quantification of metabolite levels by using U-(13)C-labelled E. coli extracts as internal standards. Known amounts of labelled E. coli extract were added into the parasite samples, as well as calibration standards, and used to obtain calibration curves enabling us to convert intensities into concentrations. This method allowed us to reliably quantify the changes of 43 intracellular metabolites and 32 extracellular metabolites in the medium over time. Based on the absolute quantification, we were able to compute consumption and production fluxes. These quantitative data can now be used to optimise computational models of parasite metabolism.
    Metabolomics 07/2015; 11(6). DOI:10.1007/s11306-015-0827-2 · 3.86 Impact Factor
  • Source
    • "Full inhibition of ADC will therefore only occur at sufficiently high CoA concentrations. Given that CoA concentrations in the cell can be as high as 4 mM (Bennett et al., 2009) compared with an affinity of 2 mM for the PanZ.CoA complex, we anticipate that activated ADC actually exists predominantly as the inhibited ADC-PanZ.RCoA complex in the cell. We suggest that this is the principal regulatory point for pantothenate biosynthesis and, by extension, de novo CoA "
    [Show abstract] [Hide abstract]
    ABSTRACT: Coenzyme A (CoA) is an ubiquitous and essential cofactor, synthesized from the precursor pantothenate. Vitamin biosynthetic pathways are normally tightly regulated, including the pathway from pantothenate to CoA. However, no regulation of pantothenate biosynthesis has been identified. We have recently described an additional component in the pantothenate biosynthetic pathway, PanZ, which promotes the activation of the zymogen, PanD, to form aspartate α-decarboxylase (ADC) in a CoA-dependent manner. Here we report the structure of PanZ in complex with PanD, which reveals the structural basis for the CoA dependence of this interaction and activation. In addition, we show that PanZ acts as a CoA-dependent inhibitor of ADC catalysis. This inhibitory effect can effectively regulate the biosynthetic pathway to pantothenate, and thereby also regulate CoA biosynthesis. This represents a previously unobserved mode of metabolic regulation whereby a cofactor-utilizing protein negatively regulates the biosynthesis of the same cofactor. Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
    Chemistry & biology 04/2015; 22(4):492-503. DOI:10.1016/j.chembiol.2015.03.017 · 6.65 Impact Factor
Show more